Prevention & Chronic Conditions

Broadcast

Your Questions Answered: Revolutionising Thrombosis Treatment

Carolyn Lam, Jeffrey Weitz, Sneha Shah Jain, et al

Watch time: 31m 49s

Broadcast

The Science of Radiofrequency Renal Denervation

Stefan Tunev, Andrew SP Sharp

Watch time: 1h 12m 55s

Broadcast

Land Ahoy! – The Holistic Physiology Approach

Tommaso Gori, David Leistner, , et al

Watch time: 1h 2m 12s

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

The ISCHEMIA Trial: What is the Message for the Interventionalist?

Published:

01 June 2021

Citation:

European Cardiology Review 2021;16:e24.

Editorial: The EXCEL Trial

Published:

30 March 2021

Citation:

European Cardiology Review 2021;16:e09.

Bridging the Gap in a Rare Cause of Angina

Published:

03 March 2021

Citation:

European Cardiology Review 2021;16:e05.

Pharmacotherapy in Stable CAD: The ISCHEMIA Trial

Published:

03 March 2021

Citation:

European Cardiology Review 2021;16:e04.